Breakthroughs, clinical trials, and global health insights - curated from the world's leading diabetes researchers.
A biomaterial designed to travel through the bloodstream could offer a less invasive way to calm inflammation and help injured tissue repair itself. In animal studies, the injectable material improved tissue damage caused by heart…
Read full story ->
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might…
Learn more ->
Before we get into what’s new for 2026, it helps to understand what these changes actually mean for you. Diabetes…
Learn more ->
At the Medical University of South Carolina (MUSC), researcher Leonardo Ferreira, Ph.D., is leading an ambitious effort to change how…
Learn more ->
Medical innovation has really give people a shot at better heart health. About 805,000 people in the US have heart…
Learn more ->
Sanofi opens new tab has asked the U.S. Food and Drug Administration to pull its diabetes drug out of the…
Learn more ->
Curated from leading research publications
Loading feed...
